Martin W. Mackay
2022
In 2022, Martin W. Mackay earned a total compensation of $1.4M as Chief Executive Officer and Chairman at Rallybio Corp, a 52% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $198,916 |
|---|---|
| Option Awards | $691,108 |
| Salary | $491,150 |
| Other | $17,000 |
| Total | $1,398,174 |
Mackay received $691.1K in option awards, accounting for 49% of the total pay in 2022.
Mackay also received $198.9K in non-equity incentive plan, $491.2K in salary and $17K in other compensation.
Rankings
In 2022, Martin W. Mackay's compensation ranked 2,373rd out of 5,736 executives tracked by ExecPay. In other words, Mackay earned more than 58.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,373 out of 5,736 | 59th |
Division Manufacturing | 1,303 out of 3,125 | 58th |
Major group Chemicals And Allied Products | 579 out of 1,416 | 59th |
Industry group Drugs | 534 out of 1,317 | 60th |
Industry Pharmaceutical Preparations | 386 out of 963 | 60th |
Source: SEC filing on April 10, 2023.
Mackay's colleagues
We found two more compensation records of executives who worked with Martin W. Mackay at Rallybio Corp in 2022.